Fosfomycin
DrugBank ID: DB00828
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| urinary tract infection (disease) | 0.9999 | KG+DL |
| Ureaplasma urethritis | 0.9999 | DL |
| gonococcal urethritis | 0.9999 | DL |
| uterine inflammatory disease | 0.9998 | DL |
| xanthogranulomatous pyelonephritis | 0.9998 | DL |
| epiglottitis | 0.9993 | DL |
| urogenital tuberculosis | 0.9988 | DL |
| laryngitis | 0.9968 | DL |
| hyperamylasemia | 0.9947 | DL |
| polyclonal hyperviscosity syndrome | 0.9947 | DL |
| pyelitis | 0.9937 | DL |
| congenital analbuminemia | 0.9935 | DL |
| abdominal tuberculosis | 0.9918 | DL |
| blood group incompatibility | 0.9916 | DL |
| premalignant hematological system disease | 0.9904 | DL |
| IgG4-related aortitis | 0.9898 | DL |
| IgG4-related mediastinitis | 0.9898 | DL |
| IgG4-related mesenteritis | 0.9898 | DL |
| eosinophilic angiocentric fibrosis | 0.9898 | DL |
| IgG4-related pachymeningitis | 0.9894 | DL |
| monoclonal gammopathy | 0.9893 | DL |
| hematological disease associated with an acquired peripheral neuropathy | 0.9882 | DL |
| IgG4-related retroperitoneal fibrosis | 0.9868 | DL |
| septicemic plague | 0.9850 | DL |
| congenital hematological disorder | 0.9840 | DL |
| IgG4-related hepatopathy | 0.9821 | DL |
| toxocariasis | 0.9806 | DL |
| post-infectious neuralgia | 0.9798 | DL |
| sequela of COVID-19 | 0.9796 | DL |
| hepatitis C induced liver cirrhosis | 0.9787 | DL |
| herpes zoster | 0.9735 | DL |
| toxascariasis | 0.9730 | DL |
| anisakiasis | 0.9728 | DL |
| Peptostreptococcus infectious disease | 0.9726 | DL |
| peritonitis | 0.9717 | DL |
| acute gonococcal cystitis | 0.9694 | DL |
| genital herpes | 0.9657 | DL |
| AIDS-related disorder | 0.9624 | DL |
| pneumonia | 0.9598 | DL |
| hematopoietic and lymphoid system neoplasm | 0.9553 | DL |
| malignant pleural mesothelioma | 0.9487 | DL |
| meningitis (disease) | 0.9447 | DL |
| type I complement component 8 deficiency | 0.9430 | DL |
| bubonic plague | 0.9420 | DL |
| malignant visceral pleura tumor | 0.9314 | DL |
| malignant epithelioid mesothelioma | 0.9259 | DL |
| sarcomatoid mesothelioma | 0.9254 | DL |
| arachnoiditis | 0.9204 | DL |
| rhinoscleroma | 0.9160 | DL |
| appendicitis | 0.9141 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.